Carriers of Mutation Responsible for Multiple Endocrine Neoplasia Can Face Difficult Choices
Results of a multi-generational case study strengthen the case for genetic screening in cases of hereditary thyroid cancer.
Researchers Find Regional Differences in Stage of Presentation and Survival of Individuals With Thyroid Cancer
Patients are more likely to present with regional or distant metastases and experience lower rates of cancer-free survival depending on where they live.
Genetic Data Points to Potential New Therapeutic Target for Adrenocortical Carcinoma
Researchers find that overexpression of a specific gene is associated with poor survival in patients with adrenocortical carcinoma.
FDA Approves First Fentanyl Nasal Spray for Breakthrough Cancer Pain
FDA approvad Lazanda (fentanyl) nasal spray for the management of breakthrough pain in adult cancer patients.
Zanubrutinib May Be Viable Option After Acalabrutinib Intolerance in B-Cell Malignancies
Pelabresib/Ruxolitinib Combo Improves Splenomegaly, TSS in JAK Inhibitor–Naive Myelofibrosis
Tisagenlecleucel Yields Durable Responses in R/R Follicular Lymphoma
Ruxolitinib Shows Sustained Efficacy Over Best Available Therapy in Steroid-Refractory/Dependent cGVHD
2 Clarke Drive Cranbury, NJ 08512